The revival of psychedelic research today owes much to the respectability of its new advocates.
—Michael Pollan for The New Yorker, February 2015
Conference: Clinical Research Track
Clinical Research Track
Frederick Barrett, Ph.D.
Exploring the Interaction of Psilocybin and Meditation
Sunday, April 23, 2017 • 10:00 AM - 10:30 AM • East Hall • CE
Michael P. Bogenschutz, M.D.
Psychedelic-Assisted Treatment of Alcohol Use Disorder: A Clinical Perspective
Sunday, April 23, 2017 • 3:00 PM - 3:30 PM • East Hall • CE • CME
Anthony P. Bossis, Ph.D.
The Varieties of Religious Leaders' Experiences: The NYU Clinical Trial on the Effects of Psilocybin-Generated Mystical Experience in Religious Leaders
Sunday, April 23, 2017 • 3:30 PM - 4:00 PM • East Hall • CE
Mary Cosimano, M.S.W
Love and Connection in Psilocybin-Facilitated Research Studies
Sunday, April 23, 2017 • 12:00 PM - 12:30 PM • East Hall • CE

Alicia Danforth, Ph.D., and Charles S. Grob, M.D.
MDMA-Assisted Therapy for Social Anxiety in Autistic Adults: Lessons from Phase 2 Clinical Research
Saturday, April 22, 2017 • 11:30 AM - 12:30 PM • East Hall • CE • CME
Harriet de Wit, Ph.D.
Ecstasy in the Laboratory: Recent Advances in MDMA Research
Saturday, April 22, 2017 • 9:30 AM - 10:00 AM • Grand Ballroom • CE
Amanda Feilding
From Taboo to Treatment: The Coming of Age of Psychedelic Medicine
Friday, April 21, 2017 • 2:00 PM - 2:30 PM • East Hall
Albert Garcia-Romeu, Ph.D.
Optimizing Psilocybin Dosing for Clinical Precision: The Case for Weight-Adjusted Dosing
Sunday, April 23, 2017 • 9:00 PM - 9:30 AM • East Hall • CE
Roland R. Griffiths, Ph.D.
Johns Hopkins Psilocybin Research Project: Studies of Mystical Experience, Adverse Effects, Meditation in Healthy Volunteers, and Palliative Effects in Cancer Patients — Implications for Spirituality and Therapeutics
Sunday, April 23, 2017 • 11:00 AM - 12:00 PM • East Hall • CE • CME
Stanislov Grof, M.D.
Implications of Psychedelic Research for Psychiatry, Psychology, and Psychotherapy
Friday, April 21, 2017 • 11:00 AM - 12:00 PM • East Hall • CE • CME
Boris Heifets, M.D., Ph.D.
Toward Single Shot Therapy for Neuropsychiatric Disorders: MDMA, Ketamine and Beyond
Saturday, April 22, 2017 • 11:00 AM - 11:30 AM • East Hall • CE
Matthew W. Johnson, Ph.D.
Psychedelics as Behavior Change Agents: Addiction Recovery and Beyond
Sunday, April 23, 2017 • 2:00 PM - 2:30 PM • East Hall • CE
Mendel Kaelen
The Psychological and Neurophysiological Effects of Music in Combination with Psychedelics
Friday, April 21, 2017 • 3:00 PM - 3:30 PM • East Hall • CE
Kim Kuypers, Ph.D.
Neurobiology Underlying the Prosocial Effects of MDMA
Saturday, April 22, 2017 • 9:30 AM - 10:00 AM • Grand Ballroom • CE
Darrick May, M.D.
Examining “Bad Trips”: Acute and Enduring Positive and Negative Consequences of Challenging Experiences with Psilocybin
Sunday, April 23, 2017 • 9:30 PM - 10:00 AM • East Hall • CE
Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N.
MDMA-Assisted Psychotherapy for PTSD: Lessons from Phase 2 Clinical Trials
Saturday, April 22, 2017 • 3:00 PM - 4:00 PM • East Hall • CE • CME
David Nichols, Ph.D.
LSD Gives Up A Secret
Saturday, April 22, 2017 • 9:00 AM - 9:30 AM • East Hall • CE • CME
David Nichols, Ph.D. and Franz X. Vollenweider, M.D., F.M.H. Psych.
Q+A: Psychedelic Neuroscience
Saturday, April 22, 2017 • 10:00 AM - 10:30 AM • East Hall
David Nutt, D.M., F.R.C.P., F.R.C.Psych, F.Med.Sci.
Psychedelic Research: From Brain Imaging to Policy Reform
Friday, April 21, 2017 • 2:30 PM - 3:00 PM • East Hall • CE
Vanja Palmers
The Dependent Co-Arising of Psychedelics and Meditation
Friday, April 21, 2017 • 5:00 PM - 5:30 PM • Grand Ballroom
Torsten Passie M.D., Ph.D.
The History of MDMA: An Overview
Saturday, April 22, 2017 • 9:00 AM - 9:30 AM • Grand Ballroom • CE
Marcela Ot'alora, M.A., L.P.C. and Bruce Poulter, R.N., M.P.H.
MDMA as Profound Change Agent: Insights from MDMA-assisted Psychotherapy for PTSD Research
Saturday, April 22, 2017 • 2:00 PM - 3:00 PM • East Hall • CE
Jordi Riba, Ph.D.
New Findings from Ayahuasca Research
From Enhancing Mindfulness Abilities to Promoting Neurogenesis: New Findings on the Therapeutic Potential of Ayahuasca
Sunday, April 23, 2017 • 4:30 PM - 5:30 PM • Grand Ballroom • CE • CME
Leor Roseman, M.Sc.
Psilocybin-Assisted Therapy – Neural Changes and the Relationship Between the Acute Peak Experience and Clinical Outcomes
Friday, April 21, 2017 • 3:30 PM - 4:00 PM • East Hall • CE
Stephen Ross, M.D., and Gabby Agin-Liebes, Ph.D. Candidate
Psilocybin for Cancer-Related Anxiety and Depression: NYU Phase 2 Randomized Controlled Trial and Proposed Mechanisms
Sunday, April 23, 2017 • 4:30 PM - 5:30 PM • East Hall • CE
Ben Sessa, M.B.B.S., M.D., B.Sc., M.R.C.Psych.
MDMA Therapy: A Child Psychiatrist's Perspective
Saturday, April 22, 2017 • 5:00 PM - 5:30 PM • East Hall • CE
Franz X. Vollenweider, M.D., F.M.H. Psych.
Psychedelic 5HT2A Receptor Agonists Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders
Saturday, April 22, 2017 • 9:30 AM - 10:00 AM • East Hall • CE
Anne C. Wagner, Ph.D., C.Psych.
Combining Cognitive Behavioral Conjoint Therapy for PTSD and MDMA - First Cases and Understanding the MDMA Experience from a Cognitive Behavioral Framework
Saturday, April 22, 2017 • 5:30 PM - 6:00 PM • East Hall • CE
Rosalind Watts, DClinPsy
Patient Reports of Increased Connection to Self, Others, and World After Psilocybin for Treatment-Resistant Depression
Sunday, April 23, 2017 • 5:30 PM - 6:00 PM • East Hall • CE

Phil Wolfson M.D. and Julane Andries L.M.F.T.
MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness
Saturday, April 22, 2017 • 4:30 PM - 5:00 PM • East Hall • CE • CME